DalsnaFinance › IPOs › Vaxcyte Inc › IPO
Vaxcyte, Inc. completed its initial public offering on NASDAQ on June 12, 2020, pricing at $16.00 a share.
| Ticker | PCVX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 12, 2020 |
| Offering price | $16.00 |
| Shares offered | 15,625,000 |
| Total raised | $250M |
Vaxcyte, Inc. sold 15,625,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $250 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $250 million total recorded for the deal.
Vaxcyte, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Vaxcyte, Inc.. This page is general information, not investment advice.